AGENDA:
Oligonucleotide Therapeutics: the Future is Now – an Ionis Story
Richard Geary
Innovative and Effective Workflow Solutions for Oligonucleotides from Purification to Analysis
Bill Evans
Living in the World of RNAi Therapeutics
Mano Manoharan
Oligonucleotide Therapeutics CMC/Strategy Consultant
Executive Vice President of Drug Development at Ionis Pharmaceuticals
Downstream Process Development Scientist - Tosoh Bioscience
Senior Vice President, Innovation Chemistry & Alnylam Distinguished Scientist - Alnylam Pharmaceuticals
Main Sponsor:
